We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medical Mktg | LSE:MMG | London | Ordinary Share | GB0004150685 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/12/2008 09:34 | :-( Im not invested but 2 members of my family are breaking my balls for their paper losses on these. Its going to cost me !. | tenapen | |
10/12/2008 09:28 | Tenapen....yes very true i agree how long....but to make 100% sure a possible new drug to compete or better the best selling platinum based drug Cisplatin, im willing to give them the benefit of the doubt in the short term, only on the basis we start hearing some news early next year good or bad because as you say we have been waitng a long time. | sleepinggiant | |
10/12/2008 09:19 | Q: HOW MANY MORE YEARS CAN MMG BE EVALUATING THESE COMPOUNDS ?. | tenapen | |
10/12/2008 09:16 | No cash raising and current cash will last an extra 3 months more than expected. Phil Cartmell has steadied the ship when it comes to expenditure. I personally thought the 2 paragraphs on Ruthenium was very interesting. Small delay on Genvax but at least we know there will be news on Genvax in the 1st qtr 09 and then Ruthenium in April 09. | sleepinggiant | |
10/12/2008 08:49 | the day before the interims are announced... | jamie62 | |
09/12/2008 17:02 | Sorry to say its a late sell trade from this morning being reported now. | sleepinggiant | |
09/12/2008 16:41 | intersting late purchase at the bell | jamie62 | |
05/12/2008 08:38 | i now hear a rumour that they are fund raising - explains the delay in the interims ... | jamie62 | |
04/12/2008 10:22 | No idea behind the reasons - this is a minor play for me - I suspect that the sleepinggiant is on track though. Special resolutions: These are passed at a general meeting of which at least 21 days' notice specifying the intention to propose a resolution as a special resolution has been given. As with an extraordinary resolution, a special resolution requires a 75% majority. It is required for important matters such as alterations to the memorandum or articles of association, a change of name, or a reduction of capital to be approved by the court. Still waiting for the interim result though .... | jamie62 | |
04/12/2008 10:08 | Cheers jamie62. I hadn't clocked the bit about buying back shares (res 8) - assumed that was a technicality adn the contentious resolution was 7 - allowing directors to allot shares more freely than they've been able to do before; assumed the Bests objected to the potential dilutive effects of this authority on their stake. Any ideas why all these have been withdrawn? No longer need these powers? Expedient to drop the dispute? Other more pressing corporate/commercial developments? b | bennytheball | |
04/12/2008 10:07 | I maybe wrong but to pass the 'special' resolutions the company need a certain amout of shareholder votes....im guessing the bests voted against this resulting in not enough votes to pass 7-10 I wouldnt look into it to much...nothing major | sleepinggiant | |
04/12/2008 09:45 | SUMMARY OF CHANGES TO THE ARTICLES The changes proposed are as follows: 1. To introduce separate definitions for the Companies Acts 1985 and 2006 and to update section numbers where the corresponding provisions in the Companies Act 2006 are now in force. 2. To reflect the fact that the concept of extraordinary resolutions has not been retained under the Companies Act 2006. 3. To reflect the fact that the concept of extraordinary meetings has not been retained under the Companies Act - all meetings other than the annual general meeting are referred to as general meetings. 4. To reflect the new quorum requirements under the Companies Act 2006 for meetings convened to vary the rights attaching to a class of shares. The necessary quorum at any such meeting other than an adjourned meeting is to be two persons holding or representing by proxy at least one-third in nominal value of the issued shares of the class in question (excluding any shares of that class held as treasury shares), and at an adjourned meeting is one person holding shares of the class in question or his proxy (Article 4). 5. To include the requirement under the Companies Act 2006 that public companies must hold every AGM held after 30 September 2007 within 6 months beginning with the day following their accounting reference date (Article 51). 6. To allow proxies to vote on a show of hands and reflect the new time limits regarding appointment of proxies in accordance with the Companies Act 2006 (Articles 67, 74 and 78). 7. To allow corporate members to appoint more than one person to act as their representative at members' meetings (Article 83). 8. To provide for the directors to authorise conflicts and potential conflicts where appropriate. The Companies Act 2006 requires public companies to have an express provision in their articles to do this (Articles 93 and 110). 9. To reflect the duty of directors under the Companies Act 2006 to avoid conflicts or potential conflicts of interests with the Company (Article 109). 10. To reflect the provisions in the Companies Act 2006 relating to declaration of directors' interests (Article 111). | jamie62 | |
04/12/2008 09:44 | 7. THAT the Directors be given authority pursuant to section 95 of the Act to allot equity securities for cash and sell relevant shares held by the Company as treasury shares for cash, as if section 89(1) of the Act did not apply to such allotment or sale. 8. THAT the Company be given authority to make market purchases (as defined in section 163 of the Act) of Ordinary Shares in the capital of the Company. 9. THAT new Articles of Association of the Company be adopted. 10. THAT the name of the Company be and is hereby changed to Oncosense plc. | jamie62 | |
04/12/2008 08:52 | I wonder if this signals a resolution to the dispute with the Bests, making those resolutions obselete. If so, it smacks of the board backing down rather than the Bests. Were the resolutions just about changing the name and buying back shares in the market? | bennytheball | |
04/12/2008 08:33 | The AGM is concluded. I read this as : items 7-10 not passed. Therefore name remains MMI Group and no on-market purchase of shares (at 20p)?? What a waste of time and money. Website name to be changed back ? | jamie62 | |
01/12/2008 11:34 | mkt still bidding for 150k+ | sleepinggiant | |
01/12/2008 09:44 | nah probably waiting for the prostrate or ruthenium results and may announce both details in the interims | sleepinggiant | |
01/12/2008 09:27 | website update today: November/December: Half-year results Could mean there are unresolved issues? Auditors refusing to sign off ? Going concern questions ? | jamie62 | |
28/11/2008 16:45 | just guessing it will be next week or the week after, prob with an RNS prior to it saying what date they will be released. | sleepinggiant | |
28/11/2008 16:28 | the market is almost closed. ... | jamie62 | |
28/11/2008 10:19 | As per website : November: Half-year results. Last day, so better get on with it. | jamie62 | |
27/11/2008 13:03 | are we not due some news/update soon? | joeblogg1000 | |
27/11/2008 13:01 | Mkt bid in 150k offer in 50k | sleepinggiant | |
27/11/2008 12:49 | Could be a trick. I could buy 50,000 online this a.m. but not sell even 1,000. Assumed therefore the next share price move would be down. | bennytheball |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions